Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy
Authors:
- Masaki KaiboriMasaki Kaibori
- Kengo YoshiiKYKengo Yoshii
- Kosuke MatsuiKMKosuke Matsui
- Hideyuki MatsushimaHMHideyuki Matsushima
- Hisashi KosakaHKHisashi Kosaka
- Hidekazu YamamotoHYHidekazu Yamamoto
- Kazunori AoiKAKazunori Aoi
- Takashi YamaguchiTYTakashi Yamaguchi
- Katsunori YoshidaKYKatsunori Yoshida
- Takeshi HatanakaTHTakeshi Hatanaka
- Atsushi HiraokaAHAtsushi Hiraoka
- Toshifumi TadaToshifumi Tada
Open Access
Abstract
We developed and evaluated a modified albumin-bilirubin grade and α-fetoprotein (mALF) score, a nutritional and oncological assessment tool for patients with hepatocellular carcinoma (HCC) after surgical resection. Patients (n = 480) who underwent R0 resection between 2010 and 2020 were analyzed retrospectively. The mALF score assigned one point for a modified albumin-bilirubin (mALBI) grade 2b or 3 and one point for an α-fetoprotein (AFP) level ≥ 100 ng/mL. Patients were classified by mALF scores of 0 (mALBI grade 1/2a, AFP < 100 ng/mL), 1 (mALBI grade 2b/3 or AFP ≥ 100 ng/mL), or 2 (mALBI grade 2b/3, AFP ≥ 100 ng/mL) points. Liver reserve deteriorated and cancer progressed with increasing score. Postoperative complications (Clavien–Dindo classification ≥ 3) differed significantly among groups. The 5-year recurrence-free survival (RFS) rates were 34.8%, 11.2%, and 0.0% for 0, 1, and 2 points, respectively (1 or 2 versus 0 points, p < 0.001). The 5-year overall survival (OS) rates were 66.0%, 29.7%, and 17.8% for 0, 1, and 2 points, respectively (1 or 2 versus 0 points, p < 0.001). The mALF score was an independent prognostic predictor of RFS and OS. In HCC, the mALF score was effective for predicting postoperative complications and long-term survival.Keywords
This publication has 34 references indexed in Scilit:
- Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2015
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI GradeJournal of Clinical Oncology, 2015
- Multiplication of alpha‐fetoprotein and protein induced by vitamin K absence‐II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomyHepatology Research, 2014
- Neutrophil–lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironmentJournal of Hepatology, 2013
- Prognostic significance of a combination of pre- and post-treatment tumor markers for hepatocellular carcinoma curatively treated with hepatectomyJournal of Hepatology, 2012
- EASL Clinical Practical Guidelines: Management of Alcoholic Liver DiseaseJournal of Hepatology, 2012
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Positive Status of α‐Fetoprotein and des‐γ‐Carboxy Prothrombin: Important Prognostic Factor for Recurrent Hepatocellular CarcinomaWorld Journal of Surgery, 2004
- Score Based on Hypoalbuminemia and Elevated C-Reactive Protein Predicts Survival in Patients With Advanced Gastrointestinal CancerNutrition and Cancer, 2004
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973